Key result
This review summarizes the mechanisms of innate and adaptive immunity in the development of Coxsackievirus group B type 3 (CVB3)-induced viral myocarditis.
Why the study?
Viral myocarditis is a primary cause of dilated cardiomyopathy, and current chronic myocarditis therapies remain unsatisfactory.
This review provides a comprehensive overview of the innate and adaptive immune mechanisms involved in the development of CVB3-induced viral myocarditis.
Authors
No takes yet. Share an insight, caveat, or question.
May inform future immunomodulatory targets in viral myocarditis; leaves open prospective validation before clinical consideration.
Zhang et al. (2023) conducted a review in Viral myocarditis. Coxsackievirus group B type 3 (CVB3) infection was evaluated. This review summarizes the mechanisms of innate and adaptive immunity in the development of Coxsackievirus group B type 3 (CVB3)-induced viral myocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: